Home > Products > CEA & DR5 > Recombinant Human Anti-CEA x Anti-DR5 Bispecific Antibody (Tandem scFv)

Recombinant Human Anti-CEA x Anti-DR5 Bispecific Antibody (Tandem scFv)  (BSFV-H306)

Recombinant Anti-CEA x Anti-DR5 Bispecific Antibody (Tandem scFv) is designed to be expressed as a scFv from an anti-CEA antibody variable domains fused with a scFv from an anti-DR5 antibody variable domains. It contains a His-tag at the C/N terminus for affinity purification. The BsAb exits as monomer in reducing and non-reducing conditions. This BsAb can induce targeted apoptosis by activation of the death receptor. It is designed for the research of Breast cancer; Ovary cancer; Colon cancer; Lung cancer therapy.

Specifications

Targets
CEA & DR5
Type
Tandem scFv
Species Reactivity
Human
Target 1
CEA
Host Animal 1
Human
Target 2
DR5
Host Animal 2
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Breast cancer; Ovary cancer; Colon cancer; Lung cancer

Targets

Target 1
CEA
Gene ID
UniProt ID
Alternative Names
CEACAM5; carcinoembryonic antigen; carcinoembryonic antigen related cell adhesion molecule 5; CEA; CD66e; meconium antigen 100
Target 2
DR5
Gene ID
UniProt ID
Alternative Names
DR5; Death Receptor 5; CD262; KILLER; TRICK2; TRICKB; ZTNFR9; TRAILR2; TRICK2A; TRICK2B; TRAIL-R2; KILLER/DR5; Tumor necrosis factor receptor superfamily member 10B; TNFRSF10B

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CEA x Anti-DR5 Bispecific Antibody (Tandem scFv) (BSFV-H306). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Related products of "CEA & DR5"
Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: